Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

vertex-headquarters

Data revealed on novel CRISPR/Cas9 gene-editing therapy for first two severe haemoglobinopathy patients

November 19, 2019 Manufacturing and Production, Research and Development Vertex, crispr, pharma

Vertex and CRISPR Therapeutics have unveiled the first interim Phase 1/2 data demonstrating the safety and efficacy of the investigational …
News
capture

Bringing the clinical trial home

November 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, feature, research

Clinical trials are the backbone of healthcare and drug research, but many key patient populations have in the past been …
Feature
shutter

resTORbio shuts down Phase 3 trial in clinically symptomatic respiratory illness

November 18, 2019 Research and Development, Sales and Marketing pharma, resTORbio

US firm resTORbio has revealed its intention to terminate a Phase 3 trial of its oral, selective TORC1 inhibitor RTB101 …
News
jazz_pharma

Jazz Pharma sleep disorder drug secures CHMP backing for treatment of excessive daytime sleepiness in Europe

November 18, 2019 Research and Development, Sales and Marketing EMA, jazz pharma, narcolepsy, pharma, solriamfetol

Jazz Pharma’s solriamfetol has secured a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …
News
Facebook image

Over half of all anti-vaccine ads on Facebook stem from just two advertisers

November 15, 2019 Medical Communications, Research and Development Facebook, anti-vaccine, pharma

A new study has revealed that the largest share of anti-vaccine advertisements on Facebook originate from just two organisations, both …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

As we close in on the weekend, it’s been a week characterised by data reveals and crucial marketing approvals, including …
News
diabetes-777001_960_720

New report reveals shocking knowledge gaps around type 2 diabetes risk factors

November 14, 2019 Medical Communications, Research and Development Merck KGaA, diabetes, pharma, type 2 diabetes

A new report released on World Diabetes Day has shone a light on a startling lack of knowledge surrounding type …
News
sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

November 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Myleoma UK, appointment, multiple myeloma, pharma

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, who in her new role …
News
smart-watch-2845072_640

Wearable tech market set to double to $54 billion by 2023, report says

November 13, 2019 Research and Development, Sales and Marketing pahrma, wearble technology

A new report from GlobalData has revealed that the market for wearable technology in healthcare is expected to more than …
News
white_and_ford

Abbott CEO to step down after 21 years

November 13, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, appointment

After more than two decades at the head of the company, it has emerged that Miles D White (pictured, right) …
News
vertex-headquarters

Vertex’s cystic fibrosis portfolio to be made available across Northern Ireland and Wales

November 13, 2019 Research and Development, Sales and Marketing Kalydeco, NHS, Orkambi, Symkevi, Vertex, pharma

After drawn out negotiations and much discontent among cystic fibrosis (CF) patients and their advocates, Vertex has announced that a …
News
shutterstock_273326141

Mylan and Upjohn merger will create a new entity: Viatris

November 13, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Mylan, Pfizer, Upjohn, Viatris, pharma

The name for the new company emerging out of the merger between Pharma firm Mylan and Pfizer division Upjohn has …
News

GSK’s Nucala meets Phase 3 goal in reducing hypereosinophilic syndrome flare-ups

November 13, 2019 Research and Development GSK, Nucala, pharma

GlaxoSmithKline has unveiled new Phase 3 data for its IL-5 inhibitor Nucala (mepolizumab), revealing that the therapy met its primary …
News

Pfizer’s tofacitinib hits main goal in Phase 3 juvenile idiopathic arthritis study

November 12, 2019 Manufacturing and Production, Research and Development Pfizer, pharma, tofacitinib

Pfizer has lifted the lid on new Phase 3 data exploring the efficacy of tofacitinib in the treatment of juvenile …
News
funk

Lonza CEO to step down in 2020

November 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, appointment

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to step down from the role …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026